MAMajid Akrami

Majid Akrami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Majid Akrami has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond Nodal Status: Interactions Between Molecular Subtype, Tumor Burden, and Survival in 12,225 Patients with Breast Cancer

    by Majid Akrami, Nastaran Tavakolian, Hooman Arianpour, Amirhesam Moosazadeh, Amir Hossein Rajabi, Zahra Keumarsi, Masoumeh Ghoddusi Johari, Vahid Zangouri, Abdolrasoul Talei

    Background: Lymph node status and molecular subtype are among the most established prognostic factors in breast cancer. However, the extent to which their prognostic effects vary across different tumor size categories and clinical subgroups remains incompletely understood. We investigated the interplay between nodal status, molecular subtype, and tumor size in a large real world breast cancer cohort and developed a prognostic nomogram for individualized survival prediction. Methods: A total of 12,225 women with invasive breast cancer from the Shiraz Breast Cancer Registry were analyzed. Patients were stratified according to tumor size, lymph node status, and molecular subtype. Overall survival (OS) and disease free survival (DFS) were evaluated using Kaplan Meier analyses and subgroup comparisons. Logistic regression was performed to identify predictors of lymph node involvement, while Cox regression was used to determine independent prognostic factors. A nomogram was subsequently developed and internally validated for prediction of 3-year and 5-year OS. Results: Of 12,225 patients, 41.7% had lymph node positive disease. Across nearly all tumor size categories and molecular subtypes, nodal involvement was associated with significantly worse OS and DFS. Notably, the survival disadvantage associated with nodal positivity was more pronounced among patients with larger tumors and among those with HER2 positive and triple negative breast cancer (TNBC). Although TNBC demonstrated the lowest rate of lymph node involvement among molecular subtypes (adjusted OR 0.54, 95% CI 0.46-0.63), it appeared to show one of the largest survival gaps between node positive and node negative disease. In the overall cohort, survival outcomes generally ranked from best to worst as Luminal A, Luminal B, HER2 positive, and TNBC. However, survival differences among molecular subtypes were not consistently observed across all tumor size and nodal status subgroups. When significant differences were present, Luminal A and Luminal B tumors consistently showed superior outcomes compared with HER2 positive and TNBC tumors. Multivariable analysis identified lymph node status, tumor size, molecular subtype, lymphovascular invasion, tumor necrosis, type of surgery, radiotherapy, hormone therapy, and adjuvant chemotherapy as independent prognostic factors. A nomogram integrating clinicopathological and treatment variables demonstrated good predictive performance, with time dependent AUCs of 0.749 and 0.751 for 3 year and 5 year OS, respectively, and showed good calibration. Conclusions: The prognostic impact of lymph node status is not uniform across breast cancer subgroups and appears particularly pronounced in larger tumors and biologically aggressive subtypes. Despite a lower likelihood of nodal involvement, TNBC showed substantial outcome deterioration when nodal metastasis was present. These findings highlight the importance of jointly considering nodal status, molecular subtype, and tumor burden in prognostic assessment.

  • Assessing Recurrence Patterns of Cutaneous Squamous Cell Carcinoma (cSCC) in Post-surgical Patients in Iran: A Cross-sectional Study

    by Majid Akrami, Maryam Sadat Sadati, Zahra Marzbannia, Alireza Mohebipour, Mojgan Akbarzadeh-Jahromi, Saranaz Jangjoo, Hossein Asadi

    Background: Cutaneous squamous cell carcinoma (cSCC) is a common invasive skin malignancy. This study assesses recurrence patterns and risk factors in post-surgical Iranian patients, aiming to enhance understanding and inform prevention, diagnosis, and treatment strategies for cSCC. Materials and Methods: A cross-sectional design was used in this study to evaluate the epidemiology of cSCC among patients operated at Shahid Faghihi Hospital in Shiraz, Iran, from 2016 to 2023. It included patients with confirmed cSCC who underwent surgical treatments, ensuring comprehensive data collection through medical records and patient contact. A total of 167 records were reviewed, with 78 patients meeting the inclusion criteria. Data analysis was performed in SPSS version 27.0, applying Chi-square and Fisher’s exact tests with statistical significance set at P<0.05. Results: A total of 78 patients with cSCC were included in this study, with a mean age of 61.3±17.03 years and 28.2% being female. Tumors were predominantly located on the face (25.6%), head (23.1%), neck (20.6%), and extremities (20.6%). Margin involvement was observed in 34.6% of cases. The average tumor depth was 4.72 mm, with a mean lesion length of 24 mm and a width of 22 mm. Recurrent disease occurred in 25.6% of patients, with a mean relapse time of 11.05 months. Metastasis was observed in 19.2% of cases, and 76.9% of patients were alive at the time of analysis. Tumor recurrence was significantly associated with margin involvement, adjuvant radiation therapy, chemotherapy, and metastasis (P<0.001 for all). Patients with recurrent cSCC had significantly higher mean tumor depth (5.75 mm vs. 4.36 mm, P<0.001) and wider surgical margins (5.90 mm vs. 4.62 mm, P=0.01) compared to those without recurrence. Conclusion: This study identified surgical margins, tumor depth, and metastasis as key recurrence predictors of cSCC, emphasizing the need for personalized treatment and further research on biological and molecular factors.

  • The effectiveness of local steroid injection for the treatment of breast-limited idiopathic granulomatous mastitis: A randomized controlled clinical trial study

    by Mohammad Yasin Karami, Morteza Amestejani, Vahid Zangouri, Zahra Habibagahi, Rahele Tavakoly, Aliyeh Ranjbar, Souzan Soufizadeh Balaneji, Seyed Amin Mousavi, Mahdiyeh Sadat Seyyedi, Sedigheh Tahmasebi, et al.

    Introduction: Idiopathic granulomatous mastitis (IGM) is a rare, non-specific inflammatory breast disease. There are severalcontroversies regarding its standard treatment.Aim: We aimed to evaluate the efficacy of local corticosteroid injection compared to systemic steroids and combined treatment of both in IGM patients.Methods: In this randomized controlled clinical trial study, 115 IGM patients were randomly allocated to three groups of localsteroid injection (Betamethasone, n = 37), systemic steroid treatment (Prednisolone + MTX, n = 37), or combined treatment ofboth (n = 41) for a follow-up period of 10 months. Clinical presentations and outcomes were compared between the groups.Results: The mean age of the study patients was 35.6 years. The mean time to complete remission was 3.17, 4.33, and 6.37 months, and the relapse rate during the treatment was 0%, 5.26%, and 13.33% in the injection, combined, and systemic therapy groups, respectively. There was no significant difference between the clinical response to treatment rate and the recurrence rate during the follow-up between the groups. Four patients in the combined therapy group and 3 patients in the systemic therapy group had steroid side effects, with no side effects in the injection group.Conclusions: Steroid injection therapy is more effective than combined therapy and systemic therapy in terms of remission and relapse rate during the treatment, and is as effective as systemic therapy in the clinical response to treatment rate and the recurrence rate during the follow-up period. Regarding the lack of side effects of the steroid injection therapy, this approach could be considered among the first-line treatment options.


  • Open Access

    Investigating the Accuracy of Magnetic Resonance Imaging in the Diagnosis of Multifocal and Multicentric Breast Cancer: A Cross-Sectional Study

    by Majid Akrami, Pardis Geramifar, Nastaran Tavakolian, Masoumeh Ghoddusi Johari, Mohammad Kalantari Meibodi

    Introduction: With the rising incidence of breast cancer, the need for an effective diagnostic method, particularly in multifocal and multicenter breast cancers, becomes increasingly urgent. The present study aimed to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) in detecting multifocal and multicentric breast cancers. Materials and Methods: This ...

  • Open Access

    Pseudoangiomatous stromal hyperplasia of the breast: A case report

    by Sedigheh Tahmasebi, Atefeh Khorsand Rahim Zadeh, Vahid Zangouri, Majid Akrami, Masoumeh Ghoddusi Johari, Abdolrasoul Talei

    Pseudoangiomatous stromal hyperplasia (PASH) is a rare benign breast entity scarcely reported in the medical literature. Its pathogenesis, etiology, and optimal treatment are still unknown. PASH tumors have a broad spectrum of clinical presentations and might be mistaken for malignancies. The authors present six patients diagnosed with PASH.


  • Occurrence of residual disease in specimens of re‐excision surgery in patients with positive margins of primary quadrantectomy

    by Majid Akrami, Hamidreza Hosseinpour, Masoumeh Ghoddusi Johari, Mehdi Shariat, Vahid Zangouri, Sedigheh Tahmasebi, Zahra Keumarsi, Alireza Hosseinpour, Abdolrasoul Talei

    Performing a re-intervention following a positive margin after primary lumpectomy in patients with breast cancer entails several disadvantages such as additional costs and postponing the follow-up treatments. In the present study, we sought to measure the incidence rate of residual disease in specimens taken from breast cancer patients who had positive margins after quadrantectomy and also compare the clinical and pathological factors between patients with and without a residual disease after the secondary surgery. All of the medical records of patients undergoing quadrantectomy from December 1994 to December 2019 were collected from Shiraz Breast Cancer Registry (SBCR). Patients were divided into two subgroups of patients with and without residual disease from the secondary surgery and also with and without positive margin from the first operation. Two groups were compared in terms of all clinicopathological factors. The records of 4843 patients undergoing quadrantectomy were reviewed, of which 132 (2.3%) had involved margins. Of these, 112 patients underwent a secondary surgery and 28 had residual disease (25%). No clinicopathological factor was correlated with presence of residual cancer. Also, bigger tumor size (p < 0.001) and the presence of in situ component (p < 0.001) were associated with positive margin and hence the need for a re-excision surgery. These results revealed that the significant rate of residual disease in the specimens of the secondary surgery indicates that a re-operation (either re-excision or simple mastectomy) cannot be omitted after obtaining a positive margin from the primary quadrantectomy.


  • Open Access

    Intraoperative radiation therapy in non-breast cancer patients: A report of 26 cases from Shiraz, south of Iran

    by Majid Akrami, Hamid Nasrollahi, Mostafa Vahabi, Seyed Hassan Hamedi, Sedigheh Tahmasebi, Sareh Karbasi, Mehran Pashnesaz, Vahid Zangouri, Mohammad Yasin Karami, Ahmad Mosallaei, et al.

    Background: Intraoperative radiation therapy (IORT) is the delivery of radiation at the time of surgery. Whereas the dose delivered by external beam radiation therapy (EBRT) is limited by the tolerance of the surrounding normal tissues, IORT allows exclusion of a part or all of the dose-limiting sensitive structures by operative mobilization and/or direct shielding of these structures. The aim of the present study was to report the non-breast cancer patients' outcomes after receiving IORT in Shiraz, Iran.


  • Open Access

    Conflicts women with breast cancer face with: A qualitative study

    by Zohreh Keshavarz, Seyyede Zahra Ghaemi, Sedigheh Tahmasebi, Majid Akrami, Seyed Taghi Heydari

    Background and Aim: The prevalence of cancer in women under 50 years of age has been increased in recent years. Cancer treatment methods can lead to infertility in women with cancer. Fertility and childbearing, as the most important conflicts in the life of women with breast cancer, significantly affect their quality of life. Materials and Methods: This research is a qualitative study of content analysis type. Purposeful sampling and semi-structured individual interviews were performed for data collection. The participants were women with breast cancer referred to the Breast Disease Research Center of Shahid Motahari Clinic in Shiraz. The data were saturated after 15 interviews. To assess the validity and reliability, we used the four criteria provided by Lincoln and Guba. The conventional qualitative data analysis and MAXQDA10 software were used to analyze the qualitative data. Results: Explaining the conflicts which women with breast cancer are faced has led to the extraction of four main categories: (1) paradox of decision-making to childbearing, (2) fear, (3) sinister emotions, and (4) challenges. The results showed that the paradox of decision-making on childbearing is the most important challenge with which the patients with breast cancer are faced, causing a state of fear, anxiety, and the emergence of sinister emotions in them. Conclusion: It seems that paying more attention to preserving reproductive capacity before starting the treatment plays an important role in solving the biggest conflict in the life of breast cancer patients.